한글목차

유방 생검 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 15억 3,000만 달러에서 2026년에는 16억 5,000만 달러로, CAGR 7.5%로 확대가 전망되고 있습니다. 지난 수년간 성장 요인으로는 첨단 생검 시스템의 보급이 제한적이었던 점, 기존 수술적 생검법에 대한 의존도, 유방암 발병률 증가, 병원 및 진단센터 인프라 확충, 초음파 유도하 검사법 도입 등을 꼽을 수 있습니다.

유방 생검 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 21억 7,000만 달러에 달하며, CAGR은 7.2%에 달할 전망입니다. 예측 기간 중의 성장은 액체생검 및 영상 유도 시스템의 기술 발전, 조기 유방암 검진에 대한 인식 증가, 진단센터 및 병원의 확장, AI와 데이터 분석의 통합 발전, 맞춤형 의료 및 정밀의료 접근법의 개발로 인한 것으로 보입니다. 예측 기간 중 주요 동향으로는 최소침습 생검법 도입 증가, 액체생검 기술 활용 확대, 영상 유도 생검 시스템의 성장, 유방암 진단 및 검진 프로그램 확대, 환자 안전 및 검체 정확도 향상에 대한 집중도 강화 등을 들 수 있습니다.

유방암 발병률 증가는 향후 유방암 생검 시장 확대를 지원할 것으로 예측됩니다. 유방암은 유방 조직의 세포에 발생하는 악성 종양으로, 적절한 치료가 늦어지면 다른 부위로 전이될 수 있습니다. 유방암 발병률 증가는 평균수명의 연장, 검진 및 진단 기술의 향상, 질병에 대한 인식 증가 등의 요인과 관련이 있습니다. 유방 생검은 의심되는 유방 부위에서 조직 샘플을 채취하여 진단을 확정하고 암의 특성을 판단하기 위해 사용됩니다. 예를 들어 미국 비영리단체 Breastcancer.org에 따르면 2025년 10월 기준, 2025년 침윤성 유방암 진단을 받을 여성은 약 31만 6,950명, 비침윤성 유관암(DCIS) 신규 환자는 약 5만 9,080명으로 예측됩니다. 그 결과, 유방암 유병률 증가는 유방암 생검 시장의 확대에 기여하고 있습니다.

유방 생검 마커 시장에서 사업을 운영하는 주요 기업은 유방 생검 시술시 병변 부위 식별 정확도 향상과 마커의 변위 감소를 목표로 초음파 가시화 사이트 마커 등 혁신적인 제품 개발에 주력하고 있습니다. 초음파 가시화 사이트 마커는 영상 진단시 생검 부위의 가시성을 높이는 동시에 향후 수술적 개입을 위한 안정적인 위치 파악을 가능하게 하는 이식형 장치입니다. 예를 들어 2023년 8월, 미국에 본사를 둔 유방 생검 및 정위 기술 프로바이더인 마모톰(Mammotome)은 '하이드로마크 플러스(Hydromark Plus)'를 출시했습니다. 이 유방 생검 부위 마커는 초음파에서 병변의 가시성을 향상시켜 방사선과 의사와 외과 의사의 정확한 표적 설정을 돕고, 후속 수술시 마커 이동의 위험을 최소화합니다. 마모톰의 하이드로마크 제품군에 새롭게 추가된 하이드로마크 플러스는 시술의 신뢰성을 높이기 위해 설계되었으며, 연내 미국 전역에 출시될 예정입니다. 주요 특징으로는 높은 초음파 가시성, 유방 조직내 이동 감소, 광범위한 유방 영상 진단 및 중재적 워크플로우와의 호환성을 갖추고 있으며, 임상 결과 향상과 시술의 확실성 향상에 기여합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A breast biopsy is a procedure in which a small sample of breast tissue is removed and examined under a microscope to determine whether it is cancerous or benign. It is usually performed when a lump or abnormality is detected through imaging or a physical exam, and it can be done using different techniques such as needle biopsy or surgical biopsy, often guided by imaging methods such as ultrasound or mammography.

The major types of breast biopsy products include biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Biopsy needles are specialized medical instruments designed to collect breast tissue samples for diagnostic evaluation. The image-guided technologies include MRI-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic biopsy, CT-guided biopsy, and others, while the procedures involve needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. These are applied in hospitals, clinics, diagnostic centers, and other settings.

Tariffs are impacting the breast biopsy market by increasing the cost of imported biopsy needles, imaging guidance systems, and liquid biopsy instruments. Segments such as MRI-guided and stereotactic biopsy systems are particularly affected, with major manufacturing regions in Asia-Pacific, including China and India, facing higher import duties. This has led to elevated production and procurement costs, as well as delayed adoption in some regions. On the positive side, tariffs are encouraging local manufacturing, innovation in alternative devices, and investment in domestic production capacities.

The breast biopsy market research report is one of a series of new reports from The Business Research Company that provides breast biopsy market statistics, including breast biopsy industry global market size, regional shares, competitors with a breast biopsy market share, detailed breast biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the breast biopsy industry. This breast biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast biopsy market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, adoption of ultrasound-guided procedures.

The breast biopsy market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to technological advancements in liquid biopsy and imaging-guided systems, rising awareness of early breast cancer detection, expansion of diagnostic centers and hospitals, increasing integration of ai and data analytics, development of personalized and precision medicine approaches. Major trends in the forecast period include increasing adoption of minimally invasive biopsy procedures, rising use of liquid biopsy techniques, growth in imaging-guided biopsy systems, expansion of breast cancer diagnostic and screening programs, enhanced focus on patient safety and sample accuracy.

The growing prevalence of breast cancer is anticipated to support the expansion of the breast biopsy market going forward. Breast cancer is a malignant tumor that develops in the cells of breast tissue and may spread to other parts of the body if not treated in a timely manner. The increasing prevalence of breast cancer is linked to factors such as longer life expectancy, improved screening and detection techniques, and heightened awareness of the disease. Breast biopsy procedures are used to extract tissue samples from suspicious breast areas to confirm diagnoses and determine cancer characteristics. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, an estimated 316,950 women were projected to be diagnosed with invasive breast cancer in 2025, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast biopsy market.

Leading companies operating in the breast biopsy marker market are focusing on developing innovative products, such as ultrasound-visible site markers, to improve lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is an implantable device designed to enhance visualization of biopsy sites during imaging while providing stable localization for future surgical interventions. For example, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This breast biopsy site marker improves lesion visibility under ultrasound, supporting accurate targeting by radiologists and surgeons while minimizing the risk of marker migration during subsequent surgical procedures. As the latest addition to Mammotome's HydroMark portfolio, HydroMark Plus is engineered for improved procedural reliability and was scheduled for nationwide availability in the US by year-end. Its key features include high ultrasound conspicuity, reduced movement within breast tissue, and compatibility with a wide range of breast imaging and interventional workflows, supporting improved clinical outcomes and procedural confidence.

In May 2024, Lunit Inc., a South Korea-based medical software company, acquired Volpara Health Technologies Ltd. for an undisclosed amount. Through this acquisition, Lunit enhances its portfolio with advanced breast imaging and analytics technologies, strengthening its capabilities in early cancer detection. Volpara Health Technologies Ltd. is a New Zealand-based provider of breast biopsy solutions.

Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.

North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast biopsy market consists of revenues earned by providing services such as biopsy procedures, consultations, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast biopsy market also includes sales of biodegradable tissue markers, and semi-automated and fully automated biopsy needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Biopsy Needles; Guidance Systems; Biopsy Tables; Localization Wires; Assay Kits; Liquid Biopsy Instruments; Other Types
• 2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy; Ultrasound Guided Breast Biopsy; Mammography Guided Stereotactic Biopsy; Computed Tomography (CT) Guided Biopsy; Other Image Guided Technologies
• 3) By Procedure: Needle Breast Biopsy; Open Surgical Breast Biopsy; Liquid Breast Biopsy
• 4) By Application: Hospitals; Clinics; Diagnostic Centers; Other Applications
• Subsegments:
• 1) By Biopsy Needles: Core Biopsy Needles; Fine Needle Aspiration (FNA) Needles; Vacuum-Assisted Biopsy Needles; Automatic Biopsy Needles
• 2) By Guidance Systems: Ultrasound Guidance Systems; MRI Guidance Systems; Stereotactic Guidance Systems; Tomosynthesis Guidance Systems
• 3) By Biopsy Tables: Adjustable Biopsy Tables; Specialty Biopsy Tables; Imaging-Compatible Biopsy Tables
• 4) By Localization Wires: Hookwire Localization Devices; Radioguided Localization Wires; Magnetic Seed Localization Systems
• 5) By Assay Kits: Breast Cancer Assay Kits; Biomarker Detection Kits; Genetic Testing Kits for Breast Cancer
• 6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices; Plasma DNA Isolation Kits; Liquid Biopsy Analysis Systems
• 7) By Other Types: Biopsy Adhesives; Specimen Collection and Transport Devices; Patient Management Systems
• Companies Mentioned: Siemens Healthineers AG; Fujifilm Holdings Corporation; Becton Dickinson and Company BD; Koninklijke Philips; GE HealthCare Technologies Inc; Hologic Inc; Merit Medical Systems; Argon Medical Devices; Canon Medical Systems Corporation; Devicor Medical Products Inc; Planmed Oy; Menarini-Silicon Biosystems; Seno Medical Instruments Inc; Dilon Technologies Inc; INRAD Inc; Promaxo Inc; Cook Medical LLC; Boston Scientific Corporation; Stryker Corporation; Intact Medical Corporation; Scion Medical Technologies LLC; Galini SRL; Ethicon Surgical Technologies; Encapsule Medical Devices LLC; Cardinal Health Inc; Olympus Corporation; F Hoffmann-La Roche Ltd; Biocept Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Breast Biopsy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Breast Biopsy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Breast Biopsy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Breast Biopsy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Minimally Invasive Biopsy Procedures
  • 4.2.2 Rising Use Of Liquid Biopsy Techniques
  • 4.2.3 Growth In Imaging-Guided Biopsy Systems
  • 4.2.4 Expansion Of Breast Cancer Diagnostic And Screening Programs
  • 4.2.5 Enhanced Focus On Patient Safety And Sample Accuracy

5. Breast Biopsy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Diagnostic Centers
• 5.4 Research Laboratories
• 5.5 Oncology Centers

6. Breast Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Breast Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Breast Biopsy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Breast Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Breast Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Biopsy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Biopsy Market Segmentation

• 9.1. Global Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
• 9.2. Global Breast Biopsy Market, Segmentation By Image Guided Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
• 9.3. Global Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
• 9.4. Global Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Diagnostic Centers, Other Applications
• 9.5. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
• 9.6. Global Breast Biopsy Market, Sub-Segmentation Of Guidance Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
• 9.7. Global Breast Biopsy Market, Sub-Segmentation Of Biopsy Tables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
• 9.8. Global Breast Biopsy Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
• 9.9. Global Breast Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
• 9.10. Global Breast Biopsy Market, Sub-Segmentation Of Liquid Biopsy Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
• 9.11. Global Breast Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

10. Breast Biopsy Market Regional And Country Analysis

• 10.1. Global Breast Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Breast Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Biopsy Market

• 11.1. Asia-Pacific Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Biopsy Market

• 12.1. China Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Biopsy Market

• 13.1. India Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Biopsy Market

• 14.1. Japan Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Biopsy Market

• 15.1. Australia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Biopsy Market

• 16.1. Indonesia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Biopsy Market

• 17.1. South Korea Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Biopsy Market

• 18.1. Taiwan Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Biopsy Market

• 19.1. South East Asia Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Biopsy Market

• 20.1. Western Europe Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Biopsy Market

• 21.1. UK Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Biopsy Market

• 22.1. Germany Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Biopsy Market

• 23.1. France Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Biopsy Market

• 24.1. Italy Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Biopsy Market

• 25.1. Spain Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Biopsy Market

• 26.1. Eastern Europe Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Biopsy Market

• 27.1. Russia Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Biopsy Market

• 28.1. North America Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Biopsy Market

• 29.1. USA Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Biopsy Market

• 30.1. Canada Breast Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Biopsy Market

• 31.1. South America Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Biopsy Market

• 32.1. Brazil Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Biopsy Market

• 33.1. Middle East Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Biopsy Market

• 34.1. Africa Breast Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Breast Biopsy Market, Segmentation By Type, Segmentation By Image Guided Technology, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Biopsy Market Regulatory and Investment Landscape

36. Breast Biopsy Market Competitive Landscape And Company Profiles

• 36.1. Breast Biopsy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Breast Biopsy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Breast Biopsy Market Company Profiles
  • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Becton Dickinson and Company BD Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Koninklijke Philips Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. GE HealthCare Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Breast Biopsy Market Other Major And Innovative Companies

• Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation

38. Global Breast Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Biopsy Market

40. Breast Biopsy Market High Potential Countries, Segments and Strategies

• 40.1 Breast Biopsy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Breast Biopsy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Breast Biopsy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer